ArticleMolecular therapy. Oncology2024

The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells.

Annalisa Carretta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.